AbbVie Wins EU Approval for TEPKINLY in Combination with Lenalidomide and Rituximab
The European Commission has approved AbbVie's TEPKINLY with lenalidomide and rituximab as the first bispecific, chemotherapy-free treatment for Relapsed or Refractory Follicular Lymphoma in the second-line setting.
- Regulation | 07/07/2026 | By News Bureau
Interviews
Sachin Joshi, Managing Director and Co-Founder, PharmNXT
Sachin Joshi, Managing Director and Co-Founder, PharmNXT, discusses biologics supply chains, single-use technologies, localisation, and the future of biologics manufacturing, in an exclusive interview with Pharma In...
Greg Killian, SVP and Global Head-Life Sciences and Health Care Business, EPAM Systems
Organisations are increasingly leveraging Artificial Intelligence (AI), data, and digital engineering to drive innovation and operational excellence. Greg Killian, Senior Vice President (SVP) and Global Head–L...
Arushi Jain, Director, Akums Drugs & Pharmaceuticals
Arushi Jain, Director, Akums Drugs & Pharmaceuticals, shares her insights with Pharma Industrial India on pharma inspection readiness, quality assurance, automation, data analytics, and digital transformation in...
Articles
How Expanding Access to Chelation Therapy Is Reshaping Wilson Disease Management in India
India’s rare disease landscape is shifting from innovation to access, with improved availability of chelation therapies like Trientine highlighting how regulatory pathways, industry efforts and evolving clinic...
The Invisible Risk in Cleanrooms
Why must personnel apparel be taken seriously? Using Personal Protective Equipment (PPE) is one of the most important contamination control decisions in pharmaceutical manufacturing....
Why Manufacturing Discipline is Becoming a True Differentiator in Generic Pharmaceuticals
Discipline has become the real competitive advantage in generic pharmaceuticals, overtaking scale, speed and low cost as the main drivers of success....
Blog
Building a Resilient Pharma Supply Chain in India: Challenges, Innovations and the Road Ahead
By Darshana Daga
PRIP Scheme Set for Rollout: Key Highlights of the INR 5,000 Cr Initiative
By Pharma Industrial India
Latest news in...
Clean Rooms
- - BriaPro to Acquire Worldwide Rights to Soluble CD80 Immunotherapy from BriaCell
- - LEX Diagnostics wins FDA clearance for ultra-fast PCR platform to accelerate point-of-care testing
- - ASPA - CRISIL Counterfeiting Report to Debut at TAF Connect 2026
- - Biomoneta's Avata Rx Becomes First Indian Air-Decontamination Technology to Receive US FDA Approval
Next events
Appointments
Saumen Chakraborty, Member Board of Directors, PREMAS BIOTECH
Premas Biotech announced the appointment of Saumen Chakraborty to the Premas Biotech Board of Directors. “I am delighte...
Silvia Steyrer-Grube, Chief Executive Officer, CEO, Coriolis Pharma
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development o...
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy